2026. Fixed-Duration First-Line Therapy for Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) in Canada: A Canadian Expert Clinical Framework. Actualité hématologique au Canada. 5, s03 (nov. 2026), 2–16. DOI:https://doi.org/10.58931/cht.2026.5s0394.